(Q24245184)

4

0 references

Fulco Van der Veen

2

0 references

author name string

Monique H Mochtar

1

0 references

Manon Ziech

3

0 references

Anna Musters

Cochrane Database of Systematic Reviews

5

0 references

publication date

18 April 2007

0 references

published in

0 references

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005070.PUB2

Recombinant human LH supplementation versus recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rFSH. A multicentre, prospective, randomized cont

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005070.PUB2

Exogenous luteinizing hormone in controlled ovarian hyperstimulation for assisted reproduction techniques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005070.PUB2

Effects of recombinant human luteinizing hormone supplementation on ovarian stimulation and the implantation rate in down-regulated women of advanced reproductive age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005070.PUB2

Recombinant luteinizing hormone supplementation to recombinant follicle-stimulating hormone induced ovarian hyperstimulation in the GnRH-antagonist multiple-dose protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005070.PUB2

Effects of recombinant LH supplementation in women undergoing assisted reproduction with GnRH agonist down-regulation and stimulation with recombinant FSH: an opening study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005070.PUB2

Recombinant gonadotrophins associated with GnRH antagonist (cetrorelix) in ovarian stimulation for ICSI: comparison of r-FSH alone and in combination with r-LH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005070.PUB2

Evaluation of two doses of recombinant luteinizing hormone supplementation in an unselected group of women undergoing follicular stimulation for in vitro fertilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005070.PUB2

Randomized trial to compare the effect of recombinant human FSH (follitropin alfa) with or without recombinant human LH in women undergoing assisted reproduction treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005070.PUB2

Comparative efficacy and safety of cetrorelix with or without mid-cycle recombinant LH and leuprolide acetate for inhibition of premature LH surges in assisted reproduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005070.PUB2

Luteinizing hormone supplementation increases pregnancy rates in gonadotropin-releasing hormone antagonist donor cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005070.PUB2

Effects of recombinant LH (rLH) supplementation during controlled ovarian hyperstimulation (COH) in normogonadotrophic women with an initial inadequate response to recombinant FSH (rFSH) after pituitary downregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005070.PUB2

Small doses of LH activity are needed early in ovarian stimulation for better quality oocytes in IVF-ET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005070.PUB2

Use of recombinant follicle-stimulating hormone (Gonal F) and recombinant luteinizing hormone (Luveris) for multiple follicular stimulation in patients with a suboptimal response to in vitro fertilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005070.PUB2

Effects of exogenous LH administration during ovarian stimulation of pituitary down-regulated young oocyte donors on oocyte yield and developmental competence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005070.PUB2

Pituitary and ovarian suppression after early follicular and mid-luteal administration of a LHRH agonist in a depot formulation: decapeptyl CR

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005070.PUB2

Reevaluation of the roles of luteinizing hormone and follicle-stimulating hormone in the ovulatory process

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005070.PUB2

Updated meta-analysis of recombinant follicle-stimulating hormone (FSH) versus urinary FSH for ovarian stimulation in assisted reproduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005070.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005070.PUB2

Revisiting gonadotrophin-releasing hormone agonist protocols and management of poor ovarian responses to gonadotrophins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005070.PUB2

Treatment and causes of female infertility

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005070.PUB2

The role of LH in ovarian stimulation: exogenous LH: let's design the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005070.PUB2

Recombinant follicle stimulating hormone (rFSH; Puregon) in assisted reproduction: more oocytes, more pregnancies. Results from five comparative studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005070.PUB2

Rescue of IVF cycles by HMG in pituitary down-regulated normogonadotrophic young women characterized by a poor initial response to recombinant FSH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005070.PUB2

Common statistical errors in the design and analysis of subfertility trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005070.PUB2

Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005070.PUB2

Induction of ovulation for in-vitro fertilisation using buserelin and gonadotropins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005070.PUB2

7 January 2021

Recombinant human luteinising hormone: an effective new gonadotropin preparation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005070.PUB2

7 January 2021

A prospective, randomized comparison of ovulation induction using highly purified follicle-stimulating hormone alone and with recombinant human luteinizing hormone in in-vitro fertilization

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005070.PUB2

7 January 2021

Does the addition of recombinant LH in WHO group II anovulatory women over-responding to FSH treatment reduce the number of developing follicles? A dose-finding study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005070.PUB2

7 January 2021

The use of recombinant human LH (lutropin alfa) in the late stimulation phase of assisted reproduction cycles: a double-blind, randomized, prospective study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005070.PUB2

7 January 2021

The luteal phase and early pregnancy after combined GnRH-agonist/HMG treatment for superovulation in IVF or GIFT

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005070.PUB2

7 January 2021

Steroids in the follicular fluid and the corpus luteum of the mare. A 'two-cell type' theory of ovarian steroid synthesis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005070.PUB2

7 January 2021

10.1002/14651858.CD005070.PUB2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

17443569

1 reference

Consolidated OpenCitations Corpus – April 2017